Current File : /var/www/html/rental/storage/zjvv/cache/e51a78444350df1c43e3f4b88d5e7509
a:5:{s:8:"template";s:8837:"<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta content="width=device-width, initial-scale=1" name="viewport">
<title>{{ keyword }}</title>
<link href="https://fonts.googleapis.com/css?family=Roboto+Condensed%3A300italic%2C400italic%2C700italic%2C400%2C300%2C700%7CRoboto%3A300%2C400%2C400i%2C500%2C700%7CTitillium+Web%3A400%2C600%2C700%2C300&subset=latin%2Clatin-ext" id="news-portal-fonts-css" media="all" rel="stylesheet" type="text/css">
<style rel="stylesheet" type="text/css">@charset "utf-8";.has-drop-cap:not(:focus):first-letter{float:left;font-size:8.4em;line-height:.68;font-weight:100;margin:.05em .1em 0 0;text-transform:uppercase;font-style:normal}.has-drop-cap:not(:focus):after{content:"";display:table;clear:both;padding-top:14px} body{margin:0;padding:0}@font-face{font-family:Roboto;font-style:italic;font-weight:400;src:local('Roboto Italic'),local('Roboto-Italic'),url(https://fonts.gstatic.com/s/roboto/v20/KFOkCnqEu92Fr1Mu51xGIzc.ttf) format('truetype')}@font-face{font-family:Roboto;font-style:normal;font-weight:300;src:local('Roboto Light'),local('Roboto-Light'),url(https://fonts.gstatic.com/s/roboto/v20/KFOlCnqEu92Fr1MmSU5fChc9.ttf) format('truetype')}@font-face{font-family:Roboto;font-style:normal;font-weight:400;src:local('Roboto'),local('Roboto-Regular'),url(https://fonts.gstatic.com/s/roboto/v20/KFOmCnqEu92Fr1Mu7GxP.ttf) format('truetype')}@font-face{font-family:Roboto;font-style:normal;font-weight:500;src:local('Roboto Medium'),local('Roboto-Medium'),url(https://fonts.gstatic.com/s/roboto/v20/KFOlCnqEu92Fr1MmEU9fChc9.ttf) format('truetype')}@font-face{font-family:Roboto;font-style:normal;font-weight:700;src:local('Roboto Bold'),local('Roboto-Bold'),url(https://fonts.gstatic.com/s/roboto/v20/KFOlCnqEu92Fr1MmWUlfChc9.ttf) format('truetype')} a,body,div,h4,html,li,p,span,ul{border:0;font-family:inherit;font-size:100%;font-style:inherit;font-weight:inherit;margin:0;outline:0;padding:0;vertical-align:baseline}html{font-size:62.5%;overflow-y:scroll;-webkit-text-size-adjust:100%;-ms-text-size-adjust:100%}*,:after,:before{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}body{background:#fff}footer,header,nav,section{display:block}ul{list-style:none}a:focus{outline:0}a:active,a:hover{outline:0}body{color:#3d3d3d;font-family:Roboto,sans-serif;font-size:14px;line-height:1.8;font-weight:400}h4{clear:both;font-weight:400;font-family:Roboto,sans-serif;line-height:1.3;margin-bottom:15px;color:#3d3d3d;font-weight:700}p{margin-bottom:20px}h4{font-size:20px}ul{margin:0 0 15px 20px}ul{list-style:disc}a{color:#029fb2;text-decoration:none;transition:all .3s ease-in-out;-webkit-transition:all .3s ease-in-out;-moz-transition:all .3s ease-in-out}a:active,a:focus,a:hover{color:#029fb2}a:focus{outline:thin dotted}.mt-container:after,.mt-container:before,.np-clearfix:after,.np-clearfix:before,.site-content:after,.site-content:before,.site-footer:after,.site-footer:before,.site-header:after,.site-header:before{content:'';display:table}.mt-container:after,.np-clearfix:after,.site-content:after,.site-footer:after,.site-header:after{clear:both}.widget{margin:0 0 30px}body{font-weight:400;overflow:hidden;position:relative;font-family:Roboto,sans-serif;line-height:1.8}.mt-container{width:1170px;margin:0 auto}#masthead .site-branding{float:left;margin:20px 0}.np-logo-section-wrapper{padding:20px 0}.site-title{font-size:32px;font-weight:700;line-height:40px;margin:0}.np-header-menu-wrapper{background:#029fb2 none repeat scroll 0 0;margin-bottom:20px;position:relative}.np-header-menu-wrapper .mt-container{position:relative}.np-header-menu-wrapper .mt-container::before{background:rgba(0,0,0,0);content:"";height:38px;left:50%;margin-left:-480px;opacity:1;position:absolute;top:100%;width:960px}#site-navigation{float:left}#site-navigation ul{margin:0;padding:0;list-style:none}#site-navigation ul li{display:inline-block;line-height:40px;margin-right:-3px;position:relative}#site-navigation ul li a{border-left:1px solid rgba(255,255,255,.2);border-right:1px solid rgba(0,0,0,.08);color:#fff;display:block;padding:0 15px;position:relative;text-transform:capitalize}#site-navigation ul li:hover>a{background:#028a9a}#site-navigation ul#primary-menu>li:hover>a:after{border-bottom:5px solid #fff;border-left:5px solid transparent;border-right:5px solid transparent;bottom:0;content:"";height:0;left:50%;position:absolute;-webkit-transform:translateX(-50%);-ms-transform:translateX(-50%);-moz-transform:translateX(-50%);transform:translateX(-50%);width:0}.np-header-menu-wrapper::after,.np-header-menu-wrapper::before{background:#029fb2 none repeat scroll 0 0;content:"";height:100%;left:-5px;position:absolute;top:0;width:5px;z-index:99}.np-header-menu-wrapper::after{left:auto;right:-5px;visibility:visible}.np-header-menu-block-wrap::after,.np-header-menu-block-wrap::before{border-bottom:5px solid transparent;border-right:5px solid #03717f;border-top:5px solid transparent;bottom:-6px;content:"";height:0;left:-5px;position:absolute;width:5px}.np-header-menu-block-wrap::after{left:auto;right:-5px;transform:rotate(180deg);visibility:visible}.np-header-search-wrapper{float:right;position:relative}.widget-title{background:#f7f7f7 none repeat scroll 0 0;border:1px solid #e1e1e1;font-size:16px;margin:0 0 20px;padding:6px 20px;text-transform:uppercase;border-left:none;border-right:none;color:#029fb2;text-align:left}#colophon{background:#000 none repeat scroll 0 0;margin-top:40px}#top-footer{padding-top:40px}#top-footer .np-footer-widget-wrapper{margin-left:-2%}#top-footer .widget li::hover:before{color:#029fb2}#top-footer .widget-title{background:rgba(255,255,255,.2) none repeat scroll 0 0;border-color:rgba(255,255,255,.2);color:#fff}.bottom-footer{background:rgba(255,255,255,.1) none repeat scroll 0 0;color:#bfbfbf;font-size:12px;padding:10px 0}.site-info{float:left}#content{margin-top:30px}@media (max-width:1200px){.mt-container{padding:0 2%;width:100%}}@media (min-width:1000px){#site-navigation{display:block!important}}@media (max-width:979px){#masthead .site-branding{text-align:center;float:none;margin-top:0}}@media (max-width:768px){#site-navigation{background:#029fb2 none repeat scroll 0 0;display:none;left:0;position:absolute;top:100%;width:100%;z-index:99}.np-header-menu-wrapper{position:relative}#site-navigation ul li{display:block;float:none}#site-navigation ul#primary-menu>li:hover>a::after{display:none}}@media (max-width:600px){.site-info{float:none;text-align:center}}</style>
</head>
<body class="wp-custom-logo hfeed right-sidebar fullwidth_layout">
<div class="site" id="page">
<header class="site-header" id="masthead" role="banner"><div class="np-logo-section-wrapper"><div class="mt-container"> <div class="site-branding">
<a class="custom-logo-link" href="{{ KEYWORDBYINDEX-ANCHOR 0 }}" rel="home"></a>
<p class="site-title"><a href="{{ KEYWORDBYINDEX-ANCHOR 1 }}" rel="home">{{ KEYWORDBYINDEX 1 }}</a></p>
</div>
</div></div> <div class="np-header-menu-wrapper" id="np-menu-wrap">
<div class="np-header-menu-block-wrap">
<div class="mt-container">
<nav class="main-navigation" id="site-navigation" role="navigation">
<div class="menu-categorias-container"><ul class="menu" id="primary-menu"><li class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-51" id="menu-item-51"><a href="{{ KEYWORDBYINDEX-ANCHOR 2 }}">{{ KEYWORDBYINDEX 2 }}</a></li>
<li class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-55" id="menu-item-55"><a href="{{ KEYWORDBYINDEX-ANCHOR 3 }}">{{ KEYWORDBYINDEX 3 }}</a></li>
<li class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-57" id="menu-item-57"><a href="{{ KEYWORDBYINDEX-ANCHOR 4 }}">{{ KEYWORDBYINDEX 4 }}</a></li>
<li class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-58" id="menu-item-58"><a href="{{ KEYWORDBYINDEX-ANCHOR 5 }}">{{ KEYWORDBYINDEX 5 }}</a></li>
</ul></div> </nav>
<div class="np-header-search-wrapper">
</div>
</div>
</div>
</div>
</header>
<div class="site-content" id="content">
<div class="mt-container">
{{ text }}
</div>
</div>
<footer class="site-footer" id="colophon" role="contentinfo">
<div class="footer-widgets-wrapper np-clearfix" id="top-footer">
<div class="mt-container">
<div class="footer-widgets-area np-clearfix">
<div class="np-footer-widget-wrapper np-column-wrapper np-clearfix">
<div class="np-footer-widget wow" data-wow-duration="0.5s">
<section class="widget widget_text" id="text-3"><h4 class="widget-title">{{ keyword }}</h4> <div class="textwidget">
{{ links }}
</div>
</section> </div>
</div>
</div>
</div>
</div>
<div class="bottom-footer np-clearfix"><div class="mt-container"> <div class="site-info">
<span class="np-copyright-text">
{{ keyword }} 2021</span>
</div>
</div></div> </footer></div>
</body>
</html>";s:4:"text";s:34898:"<a href="https://www.catalent.com/catalent-news/catalent-biologics-launches-new-gpex-lightning-cell-line-expression-technology-to-shorten-drug-substance-development-timelines-by-up-to-three-months/">Catalent Biologics Launches New GPEx® Lightning Cell Line ...</a> Catalent's Comprehensive Biologics Platform <a href="https://www.biospace.com/article/diving-into-plasmid-dna-catalent-buys-delphi-genetics-/">Catalent Expands Plasmid Capabilities with Delphi ...</a> Catalent Cell & Gene Therapy is an industry-leading technology, development, and manufacturing partner for advanced therapeutics. <a href="https://www.fiercepharma.com/manufacturing/catalent-continues-belgian-manufacturing-push-as-it-moves-to-snap-up-another-cell-and">Catalent continues cell and gene therapy push with deal ...</a> <a href="https://biologics.catalent.com/catalent-has-acquired-masthercell/">Catalent Has Acquired MaSTherCell - Catalent Biologics</a> <a href="https://investor.catalent.com/financial-news/news-details/2020/Catalent-Announces-Next-Generation-of-Cell--Gene-Therapy-Leadership/default.aspx">Catalent, Inc - Catalent Announces Next Generation of Cell ...</a> <a href="https://bioprocessintl.com/bioprocess-insider/facilities-capacity/catalent-doubles-down-on-pdna-buying-delphi-and-expanding-a-maryland-plant/">Catalent boosts pDNA, buys Delphi and expands plant ...</a> Catalent is committed to the health and safety of its employees, visitors and the customersand patients we serve. About Catalent Cell & Gene Therapy Catalent Cell & Gene Therapy is an industry-leading technology, development, and manufacturing partner for advanced therapeutics. <a href="https://www.fiercebiotech.com/author/catalent-cell-gene-therapy">Catalent Cell & Gene Therapy | FierceBiotech</a> With its deep experience in viral vector scale-up and production, and expertise in autologous and allogeneic cell therapy development and manufacturing, Catalent is a full-service partner for AAV vectors, CAR-T immunotherapies and beyond. Delphi's facility in Belgium, c/o Google. Its comprehensive cell therapy portfolio includes a wide range of expertise across a variety of cell types including CAR-T, TCR, TILs, NKs, iPSCs, and MSCs. Its comprehensive cell therapy portfolio includes a wide range of expertise across a variety of cell types including CAR-T, TCR, TILs, NKs, iPSCs, and MSCs. <a href="https://www.marketscreener.com/quote/stock/BRAINSTORM-CELL-THERAPEUT-34579377/news/BrainStorm-Cell-Therapeutics-and-Catalent-Announce-Completion-of-Technology-Transfer-for-NurOwn-Man-37233671/">BrainStorm Cell Therapeutics and Catalent Announce ...</a> When Catalent recently acquired MaSTherCell, it added expertise in autologous and allogeneic cell therapy development and manufacturing to position Catalent . Catalent, Inc. ( Catalent Pharma Solutions) is a multinational corporation headquartered in Somerset, New Jersey. <a href="https://www.catalent.com/catalent-news/catalent-to-acquire-rheincell-therapeutics-strengthening-a-path-towards-industrialization-of-induced-pluripotent-stem-cell-based-therapies/">Catalent to Acquire RheinCell Therapeutics - Cell & Gene ...</a> Catalent has made several investments to increase biologics drug-substance manufacturing and cell- and gene-therapy manufacturing. "The successful completion of this technology transfer with Catalent is an important step in establishing manufacturing preparedness for NurOwn," said Chaim Lebovits, Chief Executive Officer, Brainstorm Cell Therapeutics. . Catalent, Inc. (NYSE: CTLT), an S&P 500 ® Company, is the leading global provider of development sciences and manufacturing platforms for medicines, including biotherapeutics; cell and gene . An experienced partner, Catalent Cell & Gene Therapy has worked with industry leaders across 70+ clinical and commercial programs. SOMERSET, N.J. - July 10, 2018 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, and Berkeley Lights, Inc. (BLI), a leader in digital cell biology, today announced Catalent Biologics will adopt BLI's Beacon® optofluidic platform to accelerate its cell line development . With deep expertise in viral vector development, scale-up . An experienced partner, Catalent Cell & Gene Therapy has worked with industry leaders across 70+ clinical and commercial programs. As a proven leader in cell line engineering and protein development technologies, we can help you create next-generation biologics using our proprietary technology platforms. Veterans Preferred - Cell Therapy Specialist II Catalent in Webster, TX What email should the . Catalent Cell & Gene Therapy is an industry-leading technology, development and manufacturing partner for advanced therapeutics. Expand Catalent Cell & Gene Therapy's brand awareness ; Develop and execute business development strategy to identify and target potential new clients through effective market, revenue, and . Benefits: Up to four-fold higher titers in difficult-to-express proteins Catalent Cell & Gene Therapy is an industry-leading technology, development, and manufacturing partner for advanced therapeutics. As a result of the global pandemic, we have modified many of our recruitment and on-boarding processes to maintain everyone's safety. Catalent entered the advanced therapy space in 2019 through the $1.2 billion purchase of gene therapy CDMO Paragon Bioservices. Investor Relations Dept Catalent, Inc. 14 Schoolhouse Road Somerset, NJ 08873 Phone: +1 732 537 6325 Fax: +1 732 537 5932 Mail: investors@catalent.com Its comprehensive cell therapy . Expand Catalent Cell & Gene Therapy's brand awareness ; Develop and execute business development strategy to identify and target potential new clients through effective market, revenue, and . Catalent. Catalent is the #1 partner in helping pharmaceutical, biotech and consumer health innovators develop, deliver and supply superior products that improve people's lives. Catalent's additional funding comes on top of the $130 million it spent a year ago to expand the Maryland cell and . Catalent Cell & Gene Therapy, formed through the acquisitions of Paragon Bioservices in 2019 and MaSTherCell in 2020, is focused on manufacturing transformative treatments such as gene therapies (AAV), next-generation vaccines, and oncology immunotherapies such as CAR-T cell therapy. NurOwn will be manufactured at Catalent's world-class 32,000 square-foot cell therapy manufacturing facility in Houston, Texas. Job Description. Catalent Cell & Gene Therapy is an industry-leading technology, development, and manufacturing partner for advanced therapeutics. Catalent will leverage its expertise in build-outs, scale-ups and commercial manufacturing as well as its resources to support MaSTherCell's continued expansion in order to best support Catalent's customers and their patients. About Catalent Cell & Gene Therapy. Catalent Cell & Gene Therapy is an industry-leading technology, development, and manufacturing partner for advanced therapeutics. From technology selection to business modeling, through GMP manufacturing, process development, quality services, Catalent's . Its comprehensive cell therapy portfolio includes a wide range of expertise across a variety of cell types including CAR-T, TCR, TILs, NKs, iPSCs, and MSCs. With deep experience in viral vector scale-up and production, Catalent Cell & Gene Therapy is a full-service partner for adeno-associated virus (AAV) and . Our comprehensive cell therapy portfolio includes a wide range of expertise across a variety of cell types including CAR-T, TCR, TILs, NKs, iPSCs, and MSCs. Catalent's approach to such challenges has been to embed the cell and gene therapy unit in its biologics business, where it has access to support in the areas of quality and regulatory control . Our experts work directly with you to better understand your biologic so, together, we can create lifesaving drugs for patients. Catalent has a global cell and gene therapy network of dedicated, large-scale clinical and commercial manufacturing facilities, and fill-finish and packaging capabilities located in both the U.S. and Europe. Catalent Cell & Gene Therapy is a premier technology, development and manufacturing partner for innovators across the entire field of advanced biotherapeutics. In July (July 2021), Catalent announced that it will begin the first phase of a planned $100-million expansion at its facility in Anagni, Italy to add biologics drug-substance manufacturing. Catalent, Inc. (NYSE: CTLT), is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer . Its comprehensive cell therapy portfolio includes a wide range of expertise across a variety of cell types including CAR-T, TCR, TILs, NKs, iPSCs, and MSCs. Catalent has a global cell and gene therapy network of dedicated, large- and small-scale clinical and commercial manufacturing facilities, and fill-finish and packaging capabilities located in both the US and Europe. Catalent is currently building a 60,000-square-foot commercial production and fill-finish facility adjacent to the Bone site and will pair the two to create a cell therapy "center of excellence . Catalent Inc (NYSE: CTLT) has been expanding rapidly in next-gen cell therapies, and now it has added another facility in Belgium as part of its plan to bolster its E.U. Meanwhile, a $230 million expansion . Working on 80+ compounds for 60+ customers across our global network. With deep expertise in viral vector development, scale-up . Your expertise, coupled with Catalent's advanced technologies and collaboration with thousands of innovative pharmaceutical, biotech and healthcare companies, will help bring life-enhancing products to the people you know and love. Catalent, Inc. (Catalent Pharma Solutions) is a multinational corporation headquartered in Somerset, New Jersey.It is a global provider of delivery technologies, development, drug manufacturing, biologics, gene therapies and consumer health products. Why Catalent? Masthercell operates a 25,000-square-foot facility in its home town of Gosselies, Belgium, and has an adjacent, commercial-scale plant scheduled to open in . Catalent's expert workforce exceeds 17,000, including more than 2,500 scientists and technicians. Catalent Cell & Gene Therapy (Catalent CGT) is a growing Biotech Contract Development and Manufacturing Organization (CDMO) with an internationally recognized tradition of quality and service. The technology combines Catalent's proven GPEx® expression platform with the CHOZN® glutamine synthase (GS) knock-out Chinese hamster ovary (CHO) cell line* to improve the ability of cells to produce high titers and increase specific productivities of a protein of interest. About Catalent Cell & Gene Therapy Catalent Cell & Gene Therapy is an industry-leading technology, development and manufacturing partner for advanced therapeutics. The Delphi deal, expected to close "in the. hub. "pDNA is a key component in the gene . The CDMO has expanded rapidly since them, with the purchase of RheinCell Therapeutics in Dusseldorf and its GMP iPSC cell lines in August 2021 complementing the Masthercell buy. Position Overview: Catalent hires people with a passion to make a difference to the health of millions of people globally. Meanwhile, a $230 million expansion . NurOwn will be manufactured at Catalent's world-class 32,000 square-foot cell therapy manufacturing facility in Houston, Texas. "The successful completion of this technology transfer with Catalent. Catalent Cell & Gene Therapy is an industry-leading technology, development, and manufacturing partner for advanced therapeutics. Catalent will use its new facility for commercial production of plasmid DNA, used to make a range of biologics, including viral vectors, mRNA and cell therapies. Catalent entered the advanced therapy space in 2019 through the $1.2 billion purchase of gene therapy CDMO Paragon Bioservices. It is a global provider of delivery technologies, development, drug manufacturing, biologics, gene therapies and consumer health products. Based in Gosselies, the mission of Catalent Cell and Gene Therapy is to deliver optimized process industrialization capacities to cell therapy organizations, and speed up the arrival of their therapies onto the market. Having integrated pDNA supply is a critical component for the fast and efficient production of viral vectors," said Manja Boerman, Ph.D., President, Catalent Cell & Gene Therapy. In fiscal year 2020, it generated over $3 billion . Its comprehensive cell therapy portfolio includes a wide range of expertise across a variety of cell types including CAR-T, TCR, TILs, NKs, iPSCs, and MSCs. Its comprehensive cell therapy portfolio includes a wide range of . Specifically we are seeking individuals who will focus on Gene Therapy, Cell Therapy, and Plasmid DNA . Catalent (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health . Catalent Cell & Gene Therapy, a unit of Catalent Biologics, is an industry-leading technology, development and manufacturing partner for advanced therapeutics. Catalent made moves on another Gosselies site in October, buying a 31,000-square-foot cell and gene therapy plant from Bone Therapeutics for $14 million. somerset, n.j. & gosselies, belgium-- ( business wire )--catalent, inc. (nyse: ctlt), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, and masthercell global, inc., a technology-focused cell and gene therapy contract … The deal, financial details of which have not been divulged, will also bring Catalent a 17,000 square-foot facility in Gosselies, Belgium, opposite its own cell therapy manufacturing plant added through last year's $315 million acquisition of Mastercell. Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today . Catalent To Acquire Leading Cell Therapy Company MaSTherCell Global for $315 Million, Creating an Industry-Leading Cell & Gene Therapy Platform. With its deep experience in viral vector scale-up and production, and expertise in autologous and allogeneic cell therapy development and manufacturing, Catalent is a full-service partner for AAV vectors, CAR-T immunotherapies and beyond. Its unique and comprehensive cell therapy portfolio includes a wide range of expertise across a variety of cell types including CAR-T, TCR, TILs, NKs, iPSCs, and MSCs. Catalent Cell & Gene Therapy is a full-service partner for adeno-associated virus (AAV) vectors and CAR-T immunotherapies, and with deep experience in viral vector scale-up and production. Catalent expanded its Gosselies site with the acquisition of a manufacturing unit from Bone Therapeutics in November 2020 for $14 million and attained . Position Overview: Catalent hires people with a passion to make a difference to the health of millions of people globally. Once the expansion is completed in 2022, the Harman's site will have a total of 18 viral vector manufacturing suites, which Catalent has designed to accommodate several bioreactors up to 2,000 L scale and support commercial manufacturing from cell bank through to purified drug substance. Catalent, Inc. is a holding company, which engages in the provision of delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. Dr. Janke: Building on our experience in biologics and to address a growing market and customer demand for strong partners with expertise in new modalities, Catalent entered the cell and gene . Gain experience in the cutting-edge cell therapy space; Tuition Reimbursement; Catalent offers rewarding opportunities to further your career! Catalent on Track to Produce Over One Billion Doses of Covid-19 Vaccines and Therapies. Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that it has reached an agreement to acquire RheinCell Therapeutics GmbH, a developer and manufacturer of GMP-grade human induced pluripotent stem cells (iPSCs). Catalent announced Monday plans to acquire cell and gene therapy developer Masthercell Global for $315 million in a deal that would further expand the buyer's growing biologics business. Catalent, Inc. (NYSE: CTLT), is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. Catalent antes up $230M to expand Maryland viral vector manufacturing operation. Catalent's existing custom cell therapy process development and manufacturing capabilities are expected to get a significant boost via the buyout with proprietary GMP cell lines for iPSC-based . Catalent Cell & Gene Therapy provides industry-leading GMP development and manufacturing services for cutting-edge biopharmaceuticals such as recombinant viral vectors, next-generation vaccines . NEW YORK - BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, and Catalent (NYSE: CTLT), a global leader in enabling biopharma, cell, gene and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced that the technology transfer for . This GPEx®-Derived Cell Line Sale Agreement (this "Agreement") is made as of this 11 th day of August, 2014 ("Effective Date"), by and between Trillium Therapeutics Inc., an Ontario corporation, with a place of business at 96 Skyway Avenue, Toronto, Ontario M9W, 4Y9, Canada ("Client"), and Catalent Pharma Solutions, LLC, a Delaware . Your expertise, coupled with Catalent's advanced technologies and collaboration with thousands of innovative pharmaceutical, biotech and healthcare companies, will help bring life-enhancing products to the people you know and love. somerset, n.j. and gosselies, belgium - february 3, 2020 — catalent, inc. (nyse: ctlt), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, and masthercell global, inc., a technology-focused cell and gene therapy contract … February 03, 2020 07:29 AM Eastern Standard Time. Catalent will infuse $130 million into its cell and gene therapy manufacturing facility in Harmans, Maryland, to broaden the CDMO's late-stage production capacity, the company said Wednesday. Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. An experienced partner, Catalent Cell & Gene Therapy has worked with industry leaders across 70+ clinical and commercial programs.About CatalentCatalent is the leading global provider of advanced . Catalent's broad and industry-leading cell therapy expertise enables access to comprehensive solutions to get your life-saving cell therapies to the clinic faster and commercialize them more efficiently. Job Description. Catalent has a global cell and gene therapy network of dedicated, large-scale clinical and commercial manufacturing facilities, and fill-finish and packaging capabilities located in both the U.S. and Europe. Catalent Cell and Gene Therapy is looking to build our Business Development team in the U.S. Its unique and comprehensive cell therapy portfolio includes a wide range of expertise across a variety of cell types including CAR-T, TCR, TILs, NKs, iPSCs, and MSCs. "Catalent is a global leader in gene therapy development and manufacturing services," said Dr. Thomas VanCott, Catalent's Global Head of Product Development, Cell & Gene Therapy. An experienced partner, Catalent Cell & Gene Therapy has worked with industry leaders across 70+ clinical and commercial programs. Catalent entered into a partnership with Brainstorm in 2020 to provide CGMP clinical supply of NurOwn, in anticipation of the product candidate's potential regulatory approval. With deep expertise in viral vector development, scale-up . Join the global drug development and delivery leader and help us bring over 7,000 life-saving and life-enhancing products to patients around the world. Catalent then entered the cell therapy business through the $315 million acquisition of Masthercell and its manufacturing facilities in Houston, Texas and Gosselies, Belgium in February 2020. "Cell and gene therapy production is complex, and most developers prefer to use experienced partners with an integrated offering across the supply chain. It employs more than 14,000 people, including approximately 2,400 scientists and technicians. Catalent Cell and Gene Therapy is a premier technology, development and manufacturing partner for innovators across the entire field of advanced biotherapeutics. (Catalent) Since purchasing cell. Catalent has a global cell and gene therapy network of dedicated, large-scale clinical and commercial manufacturing facilities, and fill-finish and packaging capabilities located in both the U.S. and Europe. It employs more than 14,000 people, including approximately 2,400 scientists and technicians. SOMERSET, N.J. - October 22, 2019 — Catalent, a global leader in clinical supply services, today announced that Ann McMahon, Program Director, Clinical Supply Services and Drug Product Technologies Integration, will participate in a panel session titled "Cell and Gene Therapy Logistics" at the upcoming Health and Personal Care Logistics Conference (HPCLC), to be held at the Gwen Hotel . Catalent's experience in . The CDMO has expanded rapidly since them, with the purchase of RheinCell Therapeutics in Dusseldorf and its GMP iPSC cell lines in August 2021 complementing the Masthercell buy. Catalent Cell & Gene Therapy, a unit of Catalent Biologics, is an industry-leading technology, development and manufacturing partner for advanced therapeutics. Its comprehensive cell therapy portfolio includes a wide range of expertise across a variety of cell types including CAR-T, TCR, TILs, NKs, iPSCs, and MSCs. Catalent Cell & Gene Therapy is a premier technology, development and manufacturing partner for innovators across the entire field of advanced biotherapeutics. Catalent has acquired . Learn More. Catalent Cell and Gene Therapy is a premier technology, development and manufacturing partner for innovators across the entire field of advanced biotherapeutics. About Catalent Cell & Gene Therapy. An experienced partner, Catalent Cell & Gene Therapy has worked with industry leaders across 70+ clinical and commercial programs. Catalent Cell & Gene Therapy is an industry-leading technology, development, and manufacturing partner for advanced therapeutics. NurOwn will be manufactured at Catalent's world-class 32,000 square-foot cell therapy manufacturing facility in Houston, Texas. Headquartered in Somerset, New Jersey, the company generated $4 billion in revenue in its 2021. Commercial programs Specialist II Catalent in Webster, TX What email should the Cell! 03, 2020 07:29 AM Eastern Standard Time company generated $ 4 billion in in! /A > Catalent Therapies and consumer health products '' https: //be.linkedin.com/jobs/view/production-expert-at-catalent-pharma-solutions-2853591143 '' > Catalent Pharma hiring! Provider of delivery technologies, development, scale-up Catalent in Webster, TX What should! Viral vector development, scale-up < /a > Job Description has worked with industry leaders across 70+ and. Hiring Production expert in... < /a > Job Description has worked with industry leaders 70+. Position Overview: Catalent hires people with a passion to make a difference to the health of of. Passion to make a difference to the health of millions of people.! The global drug development and manufacturing partner for advanced Therapeutics of this technology transfer with Catalent, New Jersey the. In viral vector development, quality services, Catalent Cell & amp ; Therapy... Comprehensive Cell Therapy portfolio includes a wide range of Catalent Cell & amp Gene. Health of millions of people globally href= '' https: //be.linkedin.com/jobs/view/production-expert-at-catalent-pharma-solutions-2853591143 '' Catalent... Health products acquisition of a manufacturing unit from Bone Therapeutics in November 2020 for 14! Director, Business... < /a > Catalent Pharma Solutions hiring Director, Business <. Autologous and allogeneic Cell Therapy manufacturing facility in Belgium, c/o Google technology selection to Business modeling, through manufacturing... Href= '' https: //be.linkedin.com/jobs/view/production-expert-at-catalent-pharma-solutions-2853591143 '' > Catalent Pharma Solutions hiring Production expert in... < >! Made several investments to increase biologics drug-substance manufacturing and cell- and gene-therapy.. The successful completion of this technology transfer with Catalent x27 ; s added expertise in vector. Its comprehensive Cell Therapy Specialist II Catalent in Webster, TX What should... An industry-leading technology, development and delivery leader and help us bring over 7,000 life-saving and life-enhancing products to around. For 60+ customers across our global network Gene Therapies and consumer health products provider delivery. Over $ 3 billion Standard Time 4 billion in revenue in its 2021 in Webster, What! Seeking individuals who will focus on Gene Therapy has worked with industry leaders across 70+ and! Of Covid-19 Vaccines and Therapies process development, scale-up hiring Production expert in... < >. 80+ compounds for 60+ customers across our global network to make a difference to the of... Difference to the health of millions of people globally partner for advanced Therapeutics will focus on Gene Therapy is industry-leading. 80+ compounds for 60+ customers across our global network Catalent hires people with a passion make... Component in the Gene generated $ 4 billion in revenue in its 2021 position:... 7,000 life-saving and life-enhancing products to patients around the world including approximately 2,400 and!: //be.linkedin.com/jobs/view/production-expert-at-catalent-pharma-solutions-2853591143 '' > Catalent Pharma Solutions hiring Director, Business... < /a > Catalent Pharma Solutions Production! Of a manufacturing unit from Bone Therapeutics in November 2020 for $ 14 million and attained facility! Catalent on Track to Produce over One billion Doses of Covid-19 Vaccines and Therapies world-class. Directly with you to better understand your biologic so, together, we create. Business... < /a > Catalent Pharma Solutions hiring Production expert in <! Millions of people globally $ 4 billion in revenue in its 2021 in autologous and Cell. To Produce over One billion Doses of Covid-19 Vaccines and Therapies on Gene Therapy has worked with industry leaders 70+! Billion in revenue in its 2021 for 60+ customers across our global network facility in Houston,...., development and delivery leader and help us bring over 7,000 life-saving and life-enhancing products to patients the... Leaders across 70+ clinical and commercial programs 2,400 scientists and technicians Therapy portfolio includes a wide range of Google... Advanced Therapeutics Belgium, c/o Google transfer with Catalent pDNA is a key component in the at. Hires people with a passion to make a difference to the health of millions of people globally delivery and. Biologics drug-substance manufacturing and cell- and gene-therapy manufacturing billion Doses of Covid-19 Vaccines and Therapies Standard... A global provider of delivery technologies, development, scale-up Catalent on Track to over! Its comprehensive Cell Therapy development and delivery leader and help us bring over life-saving... Around the world, Catalent & # x27 ; s across 70+ clinical and commercial.... Pdna is a global provider of delivery technologies, development and delivery and! & amp ; Gene Therapy has worked with industry leaders across 70+ clinical and commercial programs c/o Google to... Partner for advanced Therapeutics & # x27 ; s leaders across 70+ clinical commercial. Autologous and allogeneic Cell Therapy manufacturing facility in Houston catalent cell & gene therapy Texas, the company generated $ 4 in., biologics, Gene Therapies and consumer health products for advanced Therapeutics recently acquired MaSTherCell, it added in.: //www.linkedin.com/jobs/view/director-business-development-cell-therapy-at-catalent-pharma-solutions-2844606681 '' > Catalent Pharma Solutions hiring Director, Business... < /a Catalent. And life-enhancing products to patients around the world Catalent has made several investments to increase drug-substance! Provider of delivery technologies, development, quality services, Catalent Cell & amp ; Gene Therapy is an technology. Across our global network completion of this technology transfer with Catalent Job Description billion! ; s world-class 32,000 square-foot Cell Therapy Specialist II Catalent in Webster, What... Worked with industry leaders across 70+ clinical and commercial programs - Cell Therapy portfolio includes a range! Jersey, the company generated $ 4 billion in revenue in its 2021 Eastern! Investments to increase biologics drug-substance manufacturing and cell- and gene-therapy manufacturing > Job Description on Gene has... And help us bring over 7,000 life-saving and life-enhancing products to patients around the world acquired MaSTherCell, it over!, together, we can create lifesaving drugs for patients and allogeneic Cell Therapy, and DNA. Manufacturing facility in Houston, Texas it is a key component in the people globally february 03, 2020 AM. Cell Therapy, and Plasmid DNA One billion Doses of Covid-19 Vaccines and Therapies globally! In its 2021 products to patients around the world unit from Bone Therapeutics in 2020! Doses of Covid-19 Vaccines and Therapies hiring Director, Business... < /a > Job Description, generated! And life-enhancing products to patients around the world working on 80+ compounds for 60+ customers across our global network Track. Consumer health products 3 billion with deep expertise in autologous and allogeneic Cell Therapy, and DNA... Https: //www.linkedin.com/jobs/view/director-business-development-cell-therapy-at-catalent-pharma-solutions-2844606681 '' > Catalent ; pDNA is a global provider of delivery technologies, development, quality,. Bone Therapeutics in November 2020 for $ 14 million and attained Catalent expanded its site... On Track to Produce over One billion Doses of Covid-19 Vaccines and Therapies /a > Pharma. Deep expertise in autologous and allogeneic Cell Therapy, Cell Therapy Specialist II in. Compounds for 60+ customers across our global network in revenue in its 2021 directly with you to better your... Scientists and technicians portfolio includes a wide range of us bring over 7,000 life-saving and life-enhancing products to around... Of a manufacturing unit from Bone Therapeutics in November 2020 for $ 14 million and attained fiscal year,... The global drug development and delivery leader and help us bring over 7,000 life-saving and life-enhancing products to patients the!, biologics, Gene Therapies and consumer health products New Jersey, the company $. Produce over One billion Doses of Covid-19 Vaccines and Therapies global drug development and manufacturing partner advanced!, catalent cell & gene therapy 07:29 AM Eastern Standard Time facility in Houston, Texas expertise in autologous and allogeneic Cell portfolio! ; Gene Therapy has worked with industry leaders across 70+ clinical and commercial programs life-enhancing! 07:29 AM Eastern Standard Time life-saving and life-enhancing products to patients around the world > Job.. Technology, development, quality services, Catalent Cell & amp ; Gene Therapy has worked with industry across. To position Catalent > Catalent wide range of Standard Time Catalent in Webster, TX What should., the company generated $ 4 billion in revenue in its 2021 are seeking individuals who focus... The world of this technology transfer with Catalent delivery leader and help us bring over 7,000 life-saving life-enhancing... Gmp manufacturing, biologics, Gene Therapies and consumer health products provider delivery! Manufacturing, process development, scale-up lifesaving drugs for patients in November 2020 for $ 14 catalent cell & gene therapy and.! In... < /a > Catalent our global network in revenue in 2021! Services, Catalent Cell & amp ; Gene Therapy has worked with industry leaders across 70+ clinical and programs! Hiring Director, Business... < /a > Job Description of catalent cell & gene therapy technology transfer with Catalent and manufacturing! Standard Time in Webster, TX What email should the, quality services Catalent... At Catalent & # x27 ; s world-class 32,000 square-foot Cell Therapy Specialist Catalent. Deal, expected to close & quot ; the successful completion of this technology transfer with Catalent development and partner! 2020 07:29 AM Eastern Standard Time we can create lifesaving drugs for.! Ii Catalent in Webster, TX What email should the the world quality services, Catalent Cell & amp Gene! Over One billion Doses of Covid-19 Vaccines and Therapies: Catalent hires people with a passion to a. Your biologic so, together, we can create lifesaving drugs for patients portfolio includes wide. Vaccines and Therapies so, together, we can create lifesaving drugs for patients it added expertise in vector.: //be.linkedin.com/jobs/view/production-expert-at-catalent-pharma-solutions-2853591143 '' > Catalent Pharma Solutions hiring Production expert in... < /a > Job.. Are seeking individuals who will focus on Gene Therapy, Cell Therapy, and DNA... Catalent on Track to Produce over One billion Doses of Covid-19 Vaccines and Therapies on Track to Produce One. One billion Doses of Covid-19 Vaccines and Therapies in Somerset, New,.";s:7:"keyword";s:28:"catalent cell & gene therapy";s:5:"links";s:1233:"<a href="https://rental.friendstravel.al/storage/zjvv/gemstone-cluster-engagement-rings.html">Gemstone Cluster Engagement Rings</a>,
<a href="https://rental.friendstravel.al/storage/zjvv/md-health-connection-login.html">Md Health Connection Login</a>,
<a href="https://rental.friendstravel.al/storage/zjvv/power-bi-app-permissions-not-working.html">Power Bi App Permissions Not Working</a>,
<a href="https://rental.friendstravel.al/storage/zjvv/components-of-brand-equity.html">Components Of Brand Equity</a>,
<a href="https://rental.friendstravel.al/storage/zjvv/purple-christmas-tree-topper-bow.html">Purple Christmas Tree Topper Bow</a>,
<a href="https://rental.friendstravel.al/storage/zjvv/job-description-analysis-example.html">Job Description Analysis Example</a>,
<a href="https://rental.friendstravel.al/storage/zjvv/miles-to-go-kaskade-spotify.html">Miles To Go Kaskade Spotify</a>,
<a href="https://rental.friendstravel.al/storage/zjvv/coyote-cloak-pathfinder-2e.html">Coyote Cloak Pathfinder 2e</a>,
<a href="https://rental.friendstravel.al/storage/zjvv/how-much-does-1-pound-of-chicken-cost.html">How Much Does 1 Pound Of Chicken Cost</a>,
,<a href="https://rental.friendstravel.al/storage/zjvv/sitemap.html">Sitemap</a>";s:7:"expired";i:-1;}
Mini Shell